Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2018 Aug 28;20(11):44. doi: 10.1007/s11908-018-0650-9

Infectious Diseases and Mass Gatherings

Van-Thuan Hoang 1,2, Philippe Gautret 1,
PMCID: PMC7088693  PMID: 30155747

Abstract

Purpose of Review

Mass gatherings (MGs) are characterized by a high concentration of people at a specific time and location. Infectious diseases are of particular concern at MGs. The aim of this review was to summarize findings in the field of infectious diseases with a variety of pathogens associated with international MGs in the last 5 years.

Recent Findings

In the context of Hajj, one of the largest religious MGs at Mecca, Saudi Arabia, respiratory tract infections are the leading cause of infectious diseases in pilgrims with a prevalence of 50–93%. The most commonly acquired respiratory viruses were human rhinovirus, followed by human coronaviruses and influenza A virus, in decreasing order. Haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae were the predominant bacteria. The prevalence of Hajj-related diarrhea ranged from 1.1 to 23.3% and etiologies included Salmonella spp., and Escherichia coli, with evidence of acquisition of antimicrobial-resistant bacteria. In other MGs such as Muslim, Christian, and Hindu religious events, sports events, and large-scale open-air festivals, outbreaks have been reported less frequently. The most common outbreaks at these events involved diseases preventable by vaccination, notably measles and influenza. Gastrointestinal infections caused by a variety of pathogens were also recorded.

Summary

Because social distancing and contact avoidance are difficult measures to implement in the context of many MGs, individual preventive measures including vaccination, use of face mask, disposable handkerchief and hand hygiene may be recommended. Nevertheless, the effectiveness of these measures has been poorly investigated in the context of MGs.

Keywords: Infectious diseases, Outbreaks, Mass gatherings, Hajj, Sport, Festival

Introduction

The WHO defines mass gatherings (MGs) as a “concentration of people at a specific location for a specific purpose over a set period of time which has the potential to strain the planning and response resources of the country or community” [1]. MGs can be either planned or spontaneous and recurrent or sporadic [1]. Planned MGs may include sporting, social, cultural, religious, and political events. Examples include music festivals, the Olympic Games, and the Hajj [2].

Spontaneous MGs, given their nature, are more difficult to plan for and may include events, such as funerals of religious and political figures [1, 2]. MGs may also include the gatherings of displaced populations due to natural disasters, conflicts, and wars [1]. Diverse health risks are associated with MGs, including transmission of infectious disease, non-communicable disease, trauma and injuries (occupational or otherwise), environmental effects (such as, heat-related illnesses, dehydration, hypothermia), illnesses related to the use of drugs and alcohol, and deliberate acts, such as terrorist attacks [1]. Infectious diseases are of particular concern at MGs [3]. In this review, we summarize recent findings in the field of infectious diseases associated with international MGs.

Results and Discussion

The Hajj (Table 1)

Table 1.

Hajj and large-scale open-air festivals—key points

Hajj—key points
 • Event: annual Muslim pilgrimage
 • Place: Mecca, Saudia Arabia
 • Population size: 2 million from 185 countries (high proportion of elderly pilgrims with co-morbidities)
 • Prevalence of respiratory symptoms in overall population of pilgrims: 50–93%
 • Pneumonia among the leading cause of admission in Saudi hospitals during the Hajj
 • Acquisition of respiratory pathogens: 13.5–34.1% rhinovirus, 12.4–14.6% non-MERS coronavirus, 1.9–7.8% influenza A virus, 7.1–36.6% Streptococcus pneumoniae, 11.4% Haemophilus influenzae, 7.5% Staphylococcus aureus
 • No case of MERS-CoV, Bordetella pertussis, Mycoplasma pneumoniae, and Chlamydia pneumoniae observed in pilgrims in recent years
 • Antibiotic consumption in overall population of pilgrims: 45–61.8%
 • Prevalence of diarrhea: 1.1–23.3%
 • Hajj-associated diarrhea mostly due to bacteria including: Salmonella spp. and Escherichia coli.
 • Evidence for acquisition of antimicrobial-resistant bacteria
Large-scale open-air festivals—key points
 • Events: music festivals and other cultural festivals in various places in the world.
 • Population size: variable but usually less than 400,000 participants (mostly young participants)
 • Outbreaks of respiratory tract infections and gastrointestinal infections are regularly reported including notably measles and mumps, influenza, diarrhea due to bacterial and viral infections.

The Hajj, an annual Muslim pilgrimage to Mecca, Saudi Arabia, is one of the largest religious MGs in the world with about two million pilgrims from 185 countries [4]. As part of the Hajj rituals, pilgrims visit various sacred places around the city of Mecca. Most of them also travel to the city of Medina to visit the second holiest site of Islam, the Prophet’s mosque containing the tomb of the Prophet Muhammad. The presence of a large number of pilgrims from different countries of the world and overcrowded condition considerably increases the risk of occurrence of infectious diseases, particularly respiratory and gastrointestinal diseases [5]. Furthermore, a vast majority of pilgrims are elderly people with a high prevalence of chronic diseases. In the past, Hajj-related cholera has been a public health problem and the main cause of morbidity and mortality among pilgrims, leading to major epidemics and international spread. Due to improved sanitary conditions in Saudi Arabia in general and at religious sites, large-scale cholera outbreaks have not been recorded during the last decades [6, 7]. Similarly, invasive meningococcal disease has been a Hajj-related public health concern with its last outbreaks (serogroup W-135) in the 2000s. However, with the strengthening of prevention through mandatory vaccination, no case of meningococcal disease has been reported in Mecca since 2006 [8, 9].

While gastrointestinal diseases and diarrhea have changed towards a lower prevalence, respiratory tract infections (RTIs) now account for the vast majority of health problems during the Hajj [4, 5]. The inevitable overcrowding conditions at the Grand Mosque in Mecca and the accommodation in tents in Mina with an average of 50 to 100 people per tent are likely responsible for the high rate of respiratory infections among Hajj pilgrims [5].

Respiratory Infections at the Hajj

Over the last 5 years, a significant number of publications from different countries based on both syndromic surveillance and PCR-based investigation of respiratory pathogen carriage were made available. Studies were conducted in out- and in-patients at health structures in Saudi Arabia or on return in pilgrim’s country of origin and in cohorts of pilgrims regardless of symptoms [1034] (Table 2).

Table 2.

Respiratory tract infections at the Hajj

Date of study Clinical setting
Place of study
Clinical findings Number of pilgrims/cases Pathogens isolated Comments/highlights References
2010 Retrospective survey of medical data registered by Iranian caravan physicians at Mecca, Medina, Arafat, and Mina, Saudi Arabia RTIs 61.82%, cough 24%, rhinorrhea 19% n, sore throat 18% 107,074 ill Iranian pilgrims RTIs were the most diagnosed diseases [10]
2013–2015 Survey conducted among ill returning pilgrims presenting to hospitals in the Midlands South West and North England, UK 202 UK pilgrims with RTI 14.4% HRV, 13.9% IAV, 6.4% IBV, 5.0% PIV virus [11]
2013–2016 In-patient of a survey admitted to the Kurmitola General Hospital isolation unit, Dhaka, Bangladesh 81 Bengali pilgrims hospitalized with RTIs 12.3% IAV, 10% IBV, 2.8% ADV, 2.8% MPV, 2.8% PIV [12]
2014 Survey conducted among ill returning pilgrims consulting at 12 hospitals in Jordan 76% cough, 50% sore throat, 41% fever, 37% rhinorrhea, 16% dyspnea 125 Jordan pilgrims with RTIs 47% HRV/EV, 12.8% HCoV and 3% IAV [13]
2014 Cross-sectional study conducted at primary health care services of the Al Noor Specialized Hospital in Medina, Saudi Arabia 66.8% acute rhinosinusitis 343 ill hospitalized pilgrims with RTI 93 (41.2%) bacterial rhinosinusitis, including 49.5% S. aureus, 15% K. pneumoniae, 8.6% E. coli, 4.3% S. pneumoniae and 3.2% H. influenzae [14]
2014–2015 Cross-sectional survey conducted in returning Hajj and Umrah pilgrims with current respiratory symptoms or fever arriving from Mecca and landing at Srinagar Airport, India. Study based on face-to-face interview 89.7% cough, 86.3% rhinorrhea, 66.2% sore throat, 49.8% fever 300 Indian pilgrims 11% influenza virus [15]
2016 Cross-sectional study conducted at an Indian medical mission in Mecca, Medina and Jeddah, Saudi Arabia 930 ill pilgrims needed secondary care, of whom 585 (62.9%) were hospitalized. 374,475 ill Indian pilgrims Infectious diseases were most commonly due to overwhelming respiratory infections (49.4%) [16]
2013–2016 Cross-sectional survey conducted in pilgrims admitted to Iranian hospitals on returning from the Hajj 3840 Iranian pilgrims hospitalized with severe acute respiratory infections 13% influenza virus [17]
2004–2013 Retrospective cohort study conducted at Al-Ansar general hospital, Medina, Saudi Arabia 59.2% productive cough, 30.1% dry cough, 44.7% dyspnea, 26.8% sore throat. 31% admitted in ICU. 1059 hospitalized pilgrims with pneumonia (23% of total hospital admissions) Organisms isolated from sputum cultures: 36.1% S. aureus, 29% K. pneumoniae, 24.3% H. influenzae, 6.5% community-acquired MRSA, 3.1% P. aeruginosa, 1% S. pneumoniae 14.9% multiple pathogen The mortality rate was 2.4% in the ward and 21.45% in the ICU [18]
2013 Cross-sectional study conducted at 15 healthcare facilities of Mecca and Medina, Saudi Arabia 38 pilgrims hospitalized with bilateral pneumonia 57.7% HRV, 23.1% IAV, 19.2% HCoV, 57.7% H. influenzae, 53.8% S. pneumoniae [19]
2016 Prospective survey conducted in 13 hospitals in Mecca and Medina, Saudi Arabia 91% cough, 87.2% difficulty breathing, 32.3% chest pain 83.1% fever, 79.4% tachypnea 266 hospitalized pilgrims with confirmed community-acquired pneumonia 19% S. pneumoniae identified by culture [20•]
2004–2009 Longitudinal survey conducted in pilgrims recruited at 1352 Hajj caravans. Study based on medical evaluation during travel 71.2% RTIs, 10.7% ILI, 0.5% pneumonia 254,823 Iranian pilgrims

357 samples tested were positive for respiratory bacteria with 15.8% C. pneumoniae, 6.6% L. pneumophila, 8.5% streptococcus, 9.1% haemophilus

105 pairs of pharyngeal samples tested were positive for respiratory virus with 36.2% ADV, 30% HRV, 20% IVB, 1.9% RSV

[21, 22]
2009 Longitudinal survey conducted in pilgrims recruited at primary healthcare centers in Riyadh, Saudi Arabia (for the mandatory pre-Hajj meningococcal vaccination). Study based on telephone interview on return 53% RTIs 1507 pilgrims RTIs were leading cause of consultation (97% of ill pilgrims) [23]
2010 Cross-sectional study conducted at Jeddah airport 1600 pilgrims 7.5% IAV [24]
2012 Longitudinal survey conducted in pilgrims recruited at a specialized Hajj travel agency, Marseille, France. Study based on medical evaluation during travel 169 French pilgrims The overall acquisition of nasal S. aureus carriage was 22.8% [25]
2012–2014 Longitudinal survey conducted in pilgrims recruited at a specialized Hajj travel agency, Marseille, France. Study based on medical evaluation during travel 80.9% cough, 46.2% ILI, 91% sore throat, 78.7% rhinorrhea, 63.0% voice failure, 21.0% dyspnea 382 French pilgrims The prevalence of cough was significantly higher among females than men. Pilgrims with chronic respiratory disease showed a slightly increased prevalence of cough. [26•]
2012–2015 Cross-sectional study conducted at Cairo International Airport, Egypt

30.4% reported symptoms consistent with ILI

14.5% laboratory-confirmed influenza

3364 Egyptian pilgrims 14.5% influenza including, 3.5% H1N1, 5.6% H3N2, 5.4% IBV [27]
2013 Longitudinal survey conducted in pilgrims recruited at a specialized Hajj travel agency, Marseille, France. Study based on medical evaluation during travel Cough 86.8% Sore throat 82.9%, ILI 47.3%, 129 French pilgrims HRV, HCoV-E229 and IAV prevalence was 13.5%, 12.4% and 7.8%, respectively. Of note, 36.6% of pilgrims acquired S. pneumoniae after the Hajj [28]
2013 Prospective cohort study conducted among pilgrims recruited at King Abdul Aziz International airport Jeddah and Mina, Saudi Arabia 1175 pilgrims The carriage rate of S. pneumoniae was 1.8% pre- and 7.1% post-Hajj [29]
2013 Cross-sectional survey conducted in pilgrims recruited at Mina encampment. Study based on post-Hajj face-to-face interview 63.4% ILI, 46.3% cough, 34.7% sore throat, 23.8% rhinorrhea 164 Australian pilgrims 25% HRV, 4% IAV, 2% HCoV [30]
2013 Cross-sectional survey (unpaired cohort) and longitudinal survey (paired cohort) conducted in pilgrims recruited on arrival at Jeddah airport. Study based on post-Hajj face-to-face interview conducted at Mina 62% ILI 1676 pilgrims The acquisition rates of HRV, human coronavirus E229 (HCoV-E229) and IAV was 34.1%, 14.6%, and 1.9%, respectively and acquisition rates of S. pneumoniae, H. influenzae and S. aureus were 12%, 11.4%, and 7.5%, respectively [31•]
2013 Cross-sectional survey conducted in pilgrims recruited at a Hajj course at Universiti Sains Malaysia (USM), Kelantan, Malaysia, at Hajj building complex, Malaysia and in Mecca, Saudi Arabia. Study based on post-Hajj self-questionnaires collected on return

93.4% respiratory symptoms

78.2% ILI

2.1% hospitalization

468 Malaysian pilgrims Most of pilgrims acquired the infection intensely at Arafat (81.2%) [32]
2013–2015 Longitudinal survey conducted in returning Hajj pilgrims arriving at Xinjiang and Gansu airports, China ILI, 1.9% 847 Chinese pilgrims 4.0% IAV, 1.7% IBV, 0.5% MPV, 0.2% RSV [33]
2016 Prospective multisite cohort study conducted in pilgrims recruited in 4 cities of India 76% pilgrims had at least one respiratory symptoms, cough 60.6%, sore throat 25.0% 807 Indian pilgrims 28% were positive for S. pneumoniae by culture methods (65% were symptomatic) and 65.9% were positive by qPCR (59% were symptomatic) None of the participants reported receiving the pneumococcal vaccine [34•]

RTIs respiratory tract infections, ILI influenza-like illness, ICU intensive care unit, S. aureus Staphylococcus aureus, S. pneumoniae Streptococcus pneumoniae, K. pneumoniae Klebsiella pneumoniae, H. influenzae Haemophilus influenzae, P. aeruginosa: Pseudomonas aeruginosa, C. pneumoniae: Chlamydia pneumoniae, L. pneumophila: Legionella pneumophila, E. coli: Escherichia coli, MRSA methicillin-resistant staphylococcus aureus, HRV human rhinovirus, EV enterovirus, HCoV human coronavirus, IAV influenza A virus, IBV influenza B virus, PIV parainfluenza virus, RSV respiratory syncytial virus, ADV adenovirus, MPV metapneumovirus

RTIs are among the leading causes of admission to hospitals in Mina, Mecca, and Medina during the Hajj period (Table 2). Most cases are upper respiratory tract infections [1016], but severe respiratory tract infections [17] and pneumonia are not uncommon among pilgrims [18, 19, 20•]. Respiratory diseases were the second cause of mortality in Indonesian pilgrims during the Hajj (following cardiovascular diseases) [35]. Among pathogens detected by PCR methods in ill pilgrims, the most common viruses were human rhinovirus (HRV), followed by human coronaviruses (HCoV) and influenza A virus (IAV). Haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae were the predominant bacteria isolated by culture [36, 37].

Cross-sectional and longitudinal cohort studies have recorded 53–93.4% prevalence of RTI symptoms among Hajj pilgrims [2123, 26•, 28, 32, 34•]. The rate of ILI varied from 1.9 to 78.2% [21, 22, 26•, 27, 28, 3033]. Cohort surveys allow evaluating the acquisition rate of respiratory pathogens regardless of symptoms. The most commonly acquired viruses were human rhinovirus (HRV) (13.5–34.1%), followed by human coronavirus E229 (HCoV-E229) (2.0–14.6%) and influenza virus (IAV) (1.9–20.0%) [21, 22, 27, 28, 30, 31•, 33]. The most commonly acquired bacteria were S. pneumoniae (7.1 to 36.6%) and S. aureus (7.5 to 22.8%) and H. influenzae (11.4%) [25, 28, 29, 31•, 34•]. Bordetella pertussis, Mycoplasma pneumoniae, and Chlamydia pneumoniae have not been detected in pilgrims in recent studies [13, 28, 31•]. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) that emerged in the Arabian Peninsula in 2012 is associated with severe acute respiratory infection with high mortality rates. Numerous studies were conducted in returning pilgrims with the aim of detecting MERS-CoV infections and all resulted negative [1113, 15, 17, 24, 27, 28, 30, 33, 3846].

Tuberculosis (TB) transmission is another concern at the Hajj, but there are no large-scale, specific studies to determine its prevalence among pilgrims [47]. A prospective cross-sectional study was conducted in Mecca, during the Hajj period in September 2015. One thousand one hundred sixty-four pilgrims with cough were selected from five countries in Africa and South Asia that are endemic for TB and 1.4% had active previously undiagnosed TB [48•]. During the Hajj in 2015, 44 cases of TB among pilgrims and non-pilgrims were diagnosed in Mecca hospitals [48•].

Gastrointestinal Diseases at the Hajj

A review on diarrhea at the Hajj published in 2015 showed a prevalence of diarrhea ranging from 1.1 to 23.3% in 14 cohort studies including 262,999 pilgrims from various countries between 2002 and 2013 [49•]. Five percent of pilgrims from Riyadh developed diarrheal symptoms during the 2009 Hajj [23]. Twenty-one percent of Iranian female pilgrims suffered from gastroenteritis during the 2011 Hajj [50]. In 2013, 23.3% pilgrims from Marseille, France, had diarrhea during the Hajj [51] while a 13.7% prevalence was recorded in 2016 [52]. In the latter study, Escherichia coli was the predominant pathogen isolated from pilgrims by PCR. Enteropathogenic E. coli, enteroaggregative E. coli, and Shiga-like toxin-producing E. coli were acquired by 29.9%, 10.2%, and 6.5% pilgrims, respectively [52]. Among persons infected during the 2011–2013 Hajj and hospitalized in Saudi hospitals, the pathogens responsible for enteric infection were mostly bacteria, with a prevalence of Salmonella spp. of 11.4%, while that of diarrhea associated E. coli ranged between 1.3 and 8.8% according to pathotypes [53]. Two cases of Tropheryma whipplei were recorded in a cohort of French pilgrims during the 2013 Hajj [51].

Antibiotic Consumption During the Hajj

The frequency of infectious diseases during the Hajj results in a significant demand for antibiotic use. The rate of antibiotic use among pilgrims varied according to their nationality and year with 61.8% in Malay pilgrims in 2013 [32], 53.8% in French pilgrims in 2012 [25], 45–48.3% in Indian pilgrims in 2016 [16, 34•], and 58.5% in Iranian pilgrims in 2012 [54]. A prospective study conducted among 218 pilgrims from Marseille, France, during the periods of Hajj in 2013–2014 showed that 54.8% of the population used antibiotics because of respiratory diseases and 5.4% because of diarrhea [55]. Although the dispensing of antibiotics without a prescription has been banned in Saudi Arabia for more than 30 years [56], 27 % of Australian pilgrims used antibiotics either delivered in Saudi Arabia without prescription or purchased in Australia before traveling [57].

Hajj and Antimicrobial-Resistant Bacteria

The predominance of bacterial pathogens in Hajj-related gastrointestinal infections poses a major risk to public health through the potential emergence and transmission of antimicrobial-resistant bacteria [53]. Methicillin-resistant S. aureus had been isolated in 28% of pilgrims with acute sinusitis in 2014 [14] and 63% of pilgrims with community-acquired infections hospitalized during the Hajj in 2015 [58•]. One study addressed the carriage of resistant S. pneumoniae in a multinational cohort of pilgrims and showed that 23% of isolates were resistant to multiple antibiotics (resistant to three or more classes of antibiotics) [29]. Extended spectrum beta-lactamase Enterobacteriaceae are also common among hospitalized pilgrims. During the 2014–2015 Hajj, 47% of pilgrims attending hospitals for urinary tract infections showed blaCTX-M genes in E. coli isolates [59].

During the 2013 and 2014 Hajj seasons, studies were conducted using rectal samples obtained before and after the Hajj in cohorts of French pilgrims to assess the carriage of the blaCTX-M gene. Acquisition rates of 31.0–34.8% were observed [55, 60]. There was also a significant increase in the number of pilgrims harboring E. coli resistant to ceftriaxone and ticarcillin-clavulanic acid [60].

The prevalence of C3G-resistance was observed in 90.6% Acinetobacter baumannii isolates in a cohort of French pilgrims in 2014 [61] and in 76.2% of isolates obtained from hospitalized pilgrims suffering from community-acquired infections in 2015 [58•]. Two French pilgrims carried S. enterica, resistant to ceftriaxone, gentamycin, and colistin after the 2013 Hajj [62]. Mrc-1 resistance gene screening from rectal swabs was conducted in French pilgrims in 2013–2014 and found an acquisition rate of 9.0% after Hajj [63].

Risk factors for the spread of antibiotic-resistant bacteria at the Hajj include international travel, misuse of antibiotics, and availability of over-the-counter antibiotics [64]. However, gastrointestinal diseases and diarrhea continue to occur in pilgrims, outbreaks of food poisoning are reported, and the acquisition of multi-resistant bacteria is emerging. The ongoing monitoring of these diseases is part of the public health response regarding the Hajj [49•, 55].

Meningococcal Carriage at the Hajj

Currently, meningococcal vaccination (A, C, Y, W-135) is mandatory for all pilgrims, national and international, as well as local residents of holy cities and workers in contact with pilgrims; however, polysaccharide vaccine which does not prevent meningococcal carriage is still in use in many countries. Mandatory oral ciprofloxacin prophylaxis is provided upon arrival to all the pilgrims coming from the “meningitis belt” of sub-Saharan Africa [8, 9, 65, 66]. A cross-sectional study among pilgrims arrived at King Abdul Aziz International Airport, in Jeddah for the Hajj in 2012 showed antibody titers under the level of protection against serogroups A, C, W, and Y of only 0.1%, 0.4%, 17.4%, and 9.4%, respectively. Most of them (98.2%) had received meningococcal vaccination in the three previous years [67]. In a prospective cohort study conducted in Turkish Hajj pilgrims during 2010, the carriage prevalence of Neisseria meningitides, assessed by culture method, was 13% before and 27.0% after the Hajj with the majority being serogroup W-135 [68]. In a prospective culture-based cohort study conducted among Iranian pilgrims in 2012, 1.4% acquired N. meningitides at the Hajj [54]. A prospective study conducted in 2014 among international pilgrims at King Abdul Aziz International Airport showed 3.0% N. meningitides carriage by culture method upon arrival and 0.9% upon departure, with the majority of typable isolates being serogroup B [69]. Outbreaks of the disease including those due to serogroups not included in the required vaccines, such as serogroups B and X, are therefore possible at the Hajj. Despite the wide use of polysaccharide vaccine, it does not prevent the carriage of serogroup W-135 and subsequent transmission to unvaccinated individuals by returning pilgrims.

Others Religious Meetings

The Grand Magal of Touba, the largest Muslim pilgrimage in Senegal, has specific features. Besides its setting in a tropical environment, its population is characterized by a large range of age groups since most pilgrims travel with their family, including young children. A preliminary survey in 2015 has showed a high rate of febrile systemic illnesses and malaria (4.9%), diarrheal diseases (4.5%), and RTIs (5.2%) among ill pilgrims consulting at health care structures during the pilgrimage. The overall hospitalization rate was 3.4% including gyneco-obstetric cases (16.2%) and confirmed malaria (14.5%) [70••].

The Kumbh Mela in India is the largest MG in the world with about 100 million visitors. It posed an exciting challenge to the provision of healthcare services. Increased population density, reduced sanitation, and exposure to environmental pollutants open the way for easy transmission of pathogens [71]. During Kumbh Mela in 2013, 412,703 patients consulted at hospitals. Respiratory infections accounted for 70% of illnesses and diarrheal diseases for 5%. In total, 4429 (1.1%) were hospitalized. Gastrointestinal disease risk, including cholera, is high because of potential contamination of water and food. In addition, vaccination against cholera is no longer considered adequate or even feasible in this context [72].

The Ashura MG at Karbala is an increasingly popular religious event in Iraq with about three to four million Muslims from within and outside Iraq. In 2010, a cross-sectional study conducted in three public hospitals at Karbala city showed that about 80% of the 18,415 consultations were at emergency rooms. Febrile illness was recorded seven times more frequently during this event compared to previous events, in relation to an eight-fold increase in the population in the area during the event [73].

Other notable events include the Moulay Abdellah Amghar Moussem, an 8-day annual gathering in Morocco, that documented an increase of gastrointestinal diseases from 11 to 14% between 2009 and 2010 [74]. During the 2010 anniversary of the death (Urs) of Baba Farid, an annual MG in Pakpattan, Pakistan, 58% of 5918 people seen at 15 healthcare facilities were affected by communicable diseases, including 26% gastrointestinal illnesses and 21% RTIs [75]. Also in 2010, a cross-sectional study of 700,000 attendees to the 5-day Eid Al Adha holiday, Aqaba (one of the largest Muslim MGs in Jordan), identified 23% and 33% increases in emergency department attendance and hospital admissions, respectively; however, no food poisoning outbreaks were reported [76]. Unlike the syndromic surveillance data mentioned above that lacked reliable identification of the responsible pathogen, S. enterica serotype typhimurium was determined to cause 64 cases of gastrointestinal illness among 9000 participants in a Christian religious festival in Hamilton County, Ohio; the outbreak was associated with the consumption of pulled pork prepared in a private house and sold at the festival [77].

Large-Scale Open-Air Festivals (Table 1)

Although numerous gastrointestinal and respiratory outbreaks have been documented at large-scale open-air festivals, particularly music festivals, with thousands of participants, these events are probably neglected, in terms of public health attention, as well as surveillance and prevention of infectious disease strategies, compared to other categories of MGs [78]. Since this review was published, several outbreaks were reported in the context of festivals.

Between July 10 and 24, 2013, during the annual independence celebrations in Kiribati, the Kiribati Syndromic Surveillance System reported an increase in children presenting with severe diarrhea due to Rotavirus. In total, 1118 cases of gastroenteritis were reported and 6 (0.5%) died among 103 (9.2%) hospitalized. Most of them (93.4%) were younger than 5 years of age [79].

An outbreak of measles with 44 cases identified at an international dog show occurred in November 2014 in Slovenia, where measles virus had not been circulating for many years. Twenty-three persons were infected there and 21 were presumable secondary and tertiary cases. Most cases (39) were adults. Five were unvaccinated children [80]. Also, a multistate measles outbreak that caught global attention occurred at the Disney theme parks in California, USA [81].

The 23rd World Scout Jamboree (WSJ) in Yamagushi, Japan, from July 28 to August 8, 2015, was a MG attended by more than 33,000 participants from 155 countries. The event is designed for scouts aged 14 to 17 years to live together, experience diverse cultures, and take part in recreational activities. In this event, six cases of invasive meningococcal disease related to the WSJ were reported, affecting 19.5 per 100,000 WSJ attendees, far exceeding the annual incidence rate in Japan in 2014 (0.03 per 100,000 population) [82•].

Finally, an outbreak of measles (52 cases) was reported at music and art festivals in England and Wales between June and October 2016. Almost half of the cases occurred in participants aged 15 to 19 years. Several people who contracted measles at a festival later attended another festival when they were contagious, resulting in multiple, interconnected outbreaks. Only one confirmed case was fully vaccinated. Forty-two were not vaccinated. Nine cases were not fully vaccinated, or their immunization status was unknown [83].

Sport Events (Table 3)

Table 3.

Sport events—key points

• Events: Summer and Winter Olympics, FIFA world cup, EURO football cup
• Population size: variable 1–6 million attendees at largest events
• Outbreaks of respiratory tract infections have been reported, notably measles and influenza
• Gastrointestinal infections and diarrhea due to Salmonella spp. and norovirus have been recorded.

A review of outbreaks at large sport events including the Summer and Winter Olympics, FIFA world cup and the EURO football cup from 1984 through 2015 found little evidence for infectious outbreaks with the exception of 36 cases of influenza among participants to the Winter Olympiad in Salt Lake City in 2002 and a small outbreak of gastrointestinal disease affecting a single team during the pre-race sailing competition in Brazil in 2015, prior to the 2016 Olympics [84••].

An epidemic of measles occurred during the XXI Olympic Winter Games that were held in February 12–28, 2010, in Vancouver, Canada, with 82 cases [85]. Another epidemic of measles was noted during the 16th edition of the Italia Super Cup, international junior football tournament in Rimini, Italy, from June 2nd to 5th, 2011. Most ill individuals had not been vaccinated [86].

During the London 2012 Olympic and Paralympic Games, no major public health incidents occurred. Only a few outbreaks of gastrointestinal and respiratory infections were recorded during this period. No food-borne illness was directly linked to a Games venue, despite the tendency for those reporting them to label them as such [87]. During this event, 289 Olympic visitors were followed for sexually transmitted infections (STI), 47 new STI diagnoses were made including 15 non-specific genital infection, eight chlamydia, and eight genital warts (first episode) diagnoses. There were no new HIV or syphilis diagnoses [88].

During Euro 2012 European Football, according to national data from Ukraine, 1299 cases of acute gastroenteritis occurred in host cities, but daily notifications remained consistently below the epidemic threshold determined by Ukraine. Similarly, 109 measles cases were reported in the host cities during the tournament, only one of which occurred in a foreign visitor. This number represented about 10% of the new cases reported throughout Ukraine during the same period [89].

During the European Youth Olympic Festival in Utrecht, the Netherlands, in 2013, a prospective cohort study was conducted among 2272 participants from 49 countries. Forty-six cases of diseases were reported. Infection was the most commonly reported cause of illness (56.5% overall) with 43.5% patients reporting gastrointestinal symptoms and 26.1% respiratory symptoms [90].

Among the 2788 athletes in the Sochi 2014 Olympic Winter Games, a total of 249 illnesses were reported, resulting in an incidence of 8.9 illnesses per 100 athletes (95% CI 7.8 to 10.0). Most ill athletes suffered from respiratory symptoms (63.9%), followed by gastrointestinal symptoms (11%) with 58% caused by infections [91]. Only three cases of dengue fever were confirmed at the 2014 FIFA World Cup [92].

A recent multinational Salmonella outbreak was reported at an international youth ice hockey competition in Riga, Lativa in 2015 [93].

Among 11,274 athletes from 207 countries participating to the Rio de Janeiro 2016 Olympic Summer Games, 613 illnesses were reported, resulting in 5.4 illnesses per 100 athletes. Two hundred two individuals (47%) presented with respiratory symptoms and (n = 131; 21%) gastrointestinal symptoms with 56% (n = 346) due to infections [94]. Dengue case count was negligible and no case of Zika virus was detected [95, 96].

More recently, the Pyeong Ghang 2018 Winter Olympiad may have been hindered by a norovirus outbreak days before the event commenced. This outbreak affected mainly security staff for the games rather than athletes or visitors [97].

Conclusion

This review has some limitations. It was limited to articles written in English, which may have been a source of bias. There was a significant heterogeneity in the studies in relation to the populations studied, the clinical criteria for syndromic surveillance and the diagnostic methods applied.

Infectious diseases at MGs are dominated by respiratory tract and gastrointestinal infections. Meningitis outbreaks were also reported in some instances. Inter-human transmission of airborne diseases is favored by the temporal and spatial concentration of people. Because social distancing and contact avoidance are difficult measures to implement in the context of many MGs, individual preventive measures such as cough etiquette, the use of face mask and disposable handkerchiefs and hand hygiene may be recommended. Nevertheless, the effectiveness of these measures has been poorly investigated in the context of MGs. Most available data come from Hajj studies and results are contradictory [98].

Non-compliance with hygiene rules and inadequate sanitation are responsible for fecal–oral transmission of gastrointestinal infections. Public health measures aiming at provision of safe water and food supplies with rigorous quality control are likely the best way to limit the occurrence of gastrointestinal outbreaks at MGs. Planned organization by highly specialized teams of staff is a key element.

It should be noted that many MG-associated diseases are vaccine–preventable, including influenza, measles, mumps, meningococcal, and pneumococcal disease. Mandatory vaccination against meningitis has proven effective in the context of the Hajj. Measles and mumps and meningococcal vaccination status should certainly be verified and updated if needed in young people attending MGs. Influenza and pneumococcal vaccination should be recommended in at-risk individuals participating to MGs. This particularly applies to elderly people participating to religious MGs.

Finally, because of the evidence of circulation of resistant bacteria, at least in the Hajj context, rationalization of antibiotic consumption should be promoted.

Unfortunately, official recommendations for prevention at MGs are lacking, with the exception of the Hajj [99].

Compliance with Ethical Standards

Conflict of Interest

Philippe Gautret and Van-Thuan Hoang declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Footnotes

This article is part of the Topical Collection on Tropical, Travel, and Emerging Infections

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  • 1.World Health Organization . Public health for mass gatherings: key considerations. Geneva: WHO; 2015. [Google Scholar]
  • 2.World Health Organization . Communicable disease alert and response for mass gatherings: key considerations. Geneva: WHO; 2008. [Google Scholar]
  • 3.Al-Tawfiq JA, Memish ZA. Mass gatherings and infectious diseases: prevention, detection, and control. Infect Dis Clin N Am. 2012;26(3):725–737. doi: 10.1016/j.idc.2012.05.005. [DOI] [PubMed] [Google Scholar]
  • 4.Memish ZA, Zumla A, Alhakeem RF, Assiri A, Turkestani A, Al Harby KD, et al. Hajj: infectious disease surveillance and control. Lancet. 2014;383(9934):2073–2082. doi: 10.1016/S0140-6736(14)60381-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Abubakar I, Gautret P, Brunette GW, Blumberg L, Johnson D, Poumerol G, Memish ZA, Barbeschi M, Khan AS. Global perspectives for prevention of infectious diseases associated with mass gatherings. Lancet Infect Dis. 2012;12:66–74. doi: 10.1016/S1473-3099(11)70246-8. [DOI] [PubMed] [Google Scholar]
  • 6.Ahmed QA, Arabi YM, Memish ZA. Health risks at the Hajj. Lancet. 2006;367(9515):1008–1015. doi: 10.1016/S0140-6736(06)68429-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Zumla Alimuddin, McCloskey Brian, Endericks Tina, Azhar Esam I, Petersen Eskild. The challenges of cholera at the 2017 Hajj pilgrimage. The Lancet Infectious Diseases. 2017;17(9):895–897. doi: 10.1016/S1473-3099(17)30454-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yezli S, Assiri AM, Alhakeem RF, Turkistani AM, Alotaibi B. Meningococcal disease during the Hajj and Umrah mass gatherings. Int J Infect Dis. 2016;47:60–64. doi: 10.1016/j.ijid.2016.04.007. [DOI] [PubMed] [Google Scholar]
  • 9.Yezli Saber. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review. Travel Medicine and Infectious Disease. 2018;24:51–58. doi: 10.1016/j.tmaid.2018.05.003. [DOI] [PubMed] [Google Scholar]
  • 10.Marashi SA, Rusta H, Tabatabaei A. Chief complaints and diagnosis of patients visited by caravan physicians during hajj 2010. Iran Red Crescent Med J. 2014;16:e12858. doi: 10.5812/ircmj.12858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Atabani SF, Wilson S, Overton-Lewis C, Workman J, Kidd IM, Petersen E, Zumla A, Smit E, Osman H. Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013-2015. Int J Infect Dis. 2016;47:10–14. doi: 10.1016/j.ijid.2016.04.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Muraduzzaman AKM, Khan MH, Parveen R, Sultana S, Alam AN, Akram A, Rahman M, Shirin T. Event based surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in Bangladesh among pilgrims and travelers from the Middle East: an update for the period 2013-2016. PLoS One. 2018;13(1):e0189914. doi: 10.1371/journal.pone.0189914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Al-Abdallat MM, Rha B, Alqasrawi S, Payne DC, Iblan I, Binder AM, et al. Acute respiratory infections among returning Hajj pilgrims-Jordan, 2014. J Clin Virol. 2017;89:34–37. doi: 10.1016/j.jcv.2017.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Marglani OA, Alherabi AZ, Herzallah IR, Saati FA, Tantawy EA, Alandejani TA, Faidah HS, Bawazeer NA, Marghalani AA, Madani TA. Acute rhinosinusitis during Hajj season 2014: prevalence of bacterial infection and patterns of antimicrobial susceptibility. Travel Med Infect Dis. 2016;14:583–587. doi: 10.1016/j.tmaid.2016.11.004. [DOI] [PubMed] [Google Scholar]
  • 15.Koul PA, Mir H, Saha S, Chadha MS, Potdar V, Widdowson MA, Lal RB, Krishnan A. Influenza not MERS CoV among returning Hajj and Umrah pilgrims with respiratory illness, Kashmir, north India, 2014-15. Travel Med Infect Dis. 2017;15:45–47. doi: 10.1016/j.tmaid.2016.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Khan ID, Khan SA, Asima B, Hussaini SB, Zakiuddin M, Faisal FA. Morbidity and mortality amongst Indian Hajj pilgrims: a 3-year experience of Indian Hajj medical mission in mass-gathering medicine. J Infect Public Health. 2018;11:165–170. doi: 10.1016/j.jiph.2017.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yavarian J, Shafiei Jandaghi NZ, Naseri M, Hemmati P, Dadras M, Gouya MM, et al. Influenza virus but not MERS coronavirus circulation in Iran, 2013-2016: comparison between pilgrims and general population. Travel Med Infect Dis. 2018;2018(21):51–55. doi: 10.1016/j.tmaid.2017.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Shirah BH, Zafar SH, Alferaidi OA, Sabir AMM. Mass gathering medicine (Hajj Pilgrimage in Saudi Arabia): the clinical pattern of pneumonia among pilgrims during Hajj. J Infect Public Health. 2017;10(3):277–286. doi: 10.1016/j.jiph.2016.04.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Memish Ziad A., Almasri Malak, Turkestani Abdulhafeez, Al-Shangiti Ali M., Yezli Saber. Etiology of severe community-acquired pneumonia during the 2013 Hajj—part of the MERS-CoV surveillance program. International Journal of Infectious Diseases. 2014;25:186–190. doi: 10.1016/j.ijid.2014.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.AlBarrak A, Alotaibi B, Yassin Y, Mushi A, Maashi F, Seedahmed Y, et al. Proportion of adult community-acquired pneumonia cases attributable to Streptococcus pneumoniae among Hajj pilgrims in 2016. Int J Infect Dis. 2018;69:68–74. doi: 10.1016/j.ijid.2018.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Razavi SM, Mohazzab Torabi S, Salamati P. Treatment and prevention of acute respiratory infections among Iranian hajj pilgrims: a 5-year follow up study and review of the literature. Med J Islam Repub Iran. 2014;28:31. [PMC free article] [PubMed] [Google Scholar]
  • 22.Razavi SM, Sabouri-Kashani A, Ziaee-Ardakani H, Tabatabaei A, Karbakhsh M, Sadeghipour H, et al. Trend of diseases among Iranian pilgrims during five consecutive years based on a Syndromic Surveillance System in Hajj. Med J Islam Repub Iran. 2013;27(4):179–185. [PMC free article] [PubMed] [Google Scholar]
  • 23.Al-Jasser FS, Kabbash IA, AlMazroa MA, Memish ZA. Patterns of diseases and preventive measures among domestic hajjis from Central, Saudi Arabia. Saudi Med J. 2012;33(8):879–886. [PubMed] [Google Scholar]
  • 24.Ashshi A, Azhar E, Johargy A, Asghar A, Momenah A, Turkestani A, Alghamdi S, Memish Z, al-Ghamdi A, Alawi M, el-Kafrawy S, Farouk M, Harakeh S, Kumosani T, Makhdoum H, Barbour EK. Demographic distribution and transmission potential of influenza A and 2009 pandemic influenza A H1N1 in pilgrims. J Infect Dev Ctries. 2014;8(9):1169–1175. doi: 10.3855/jidc.4204. [DOI] [PubMed] [Google Scholar]
  • 25.Verhoeven PO, Gautret P, Haddar CH, Benkouiten S, Gagnaire J, Belhouchat K, et al. Molecular dynamics of Staphylococcus aureus nasal carriage in Hajj pilgrims. Clin Microbiol Infect. 2015;21(7):650.e5–650.e8. doi: 10.1016/j.cmi.2015.03.020. [DOI] [PubMed] [Google Scholar]
  • 26.Gautret P, Benkouiten S, Griffiths K, Sridhar S. The inevitable Hajj cough: surveillance data in French pilgrims, 2012–2014. Travel Med Infect Dis. 2015;13(6):485–489. doi: 10.1016/j.tmaid.2015.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Refaey S, Amin MM, Roguski K, Azziz-Baumgartner E, Uyeki TM, Labib M, Kandeel A. Cross-sectional survey and surveillance for influenza viruses and MERS-CoV among Egyptian pilgrims returning from Hajj during 2012-2015. Influenza Other Respir Viruses. 2017;11(1):57–60. doi: 10.1111/irv.12429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Benkouiten S, Charrel R, Belhouchat K, Drali T, Nougairede A, Salez N, Memish ZA, al Masri M, Fournier PE, Raoult D, Brouqui P, Parola P, Gautret P. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014;20:1821–1827. doi: 10.3201/eid2011.140600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Memish ZA, Al-Tawfiq JA, Almasri M, Akkad N, Yezli S, Turkestani A, et al. A cohort study of the impact and acquisition of naspharyngeal carriage of Streptococcus pneumoniae during the Hajj. Travel Med Infect Dis. 2016;14(3):242–247. doi: 10.1016/j.tmaid.2016.05.001. [DOI] [PubMed] [Google Scholar]
  • 30.Barasheed O, Rashid H, Alfelali M, Tashani M, Azeem M, Bokhary H, et al. Viral respiratory infections among Hajj pilgrims in 2013. Virol Sin. 2014;29(6):364–371. doi: 10.1007/s12250-014-3507-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Memish ZA, Assiri A, Turkestani A, Yezli S, Al Masri M, Charrel R, et al. Mass gathering and globalization of respiratory pathogens during the 2013 Hajj. Clin Microbiol Infect. 2015;21(6):571.e1–571.e8. doi: 10.1016/j.cmi.2015.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hashim S, Ayub ZN, Mohamed Z, Hasan H, Harun A, Ismail N, et al. The prevalence and preventive measures of the respiratory illness among Malaysian pilgrims in 2013 Hajj season. J Travel Med. 2016;23:tav019. doi: 10.1093/jtm/tav019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ma X, Liu F, Liu L, Zhang L, Lu M, Abudukadeer A, Wang L, Tian F, Zhen W, Yang P, Hu K. No MERS-CoV but positive influenza viruses in returning Hajj pilgrims, China, 2013-2015. BMC Infect Dis. 2017;17(1):715. doi: 10.1186/s12879-017-2791-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ganaie F, Nagaraj G, Govindan V, Basha R, Hussain M, Ashraf N, et al. Impact of Hajj on the S. pneumoniae carriage among Indian pilgrims during 2016 - a longitudinal molecular surveillance study. Travel Med Infect Dis. 2018;23:64–71. doi: 10.1016/j.tmaid.2018.04.002. [DOI] [PubMed] [Google Scholar]
  • 35.Pane M, Imari S, Alwi Q, Nyoman Kandun I, Cook AR, Samaan G. Causes of mortality for Indonesian Hajj Pilgrims: comparison between routine death certificate and verbal autopsy findings. PLoS One. 2013;8(8):e73243. doi: 10.1371/journal.pone.0073243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Gautret P, Benkouiten S, Al-Tawfiq JA, Memish ZA. Hajj-associated viral respiratory infections: a systematic review. Travel Med Infect Dis. 2016;14(2):92–109. doi: 10.1016/j.tmaid.2015.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Al-Tawfiq JA, Benkouiten S, Memish ZA. A systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae. Travel Med Infect Dis. 2018;23:6–13. doi: 10.1016/j.tmaid.2018.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Annan A, Owusu M, Marfo KS, Larbi R, Sarpong FN, Adu-Sarkodie Y, Amankwa J, Fiafemetsi S, Drosten C, Owusu-Dabo E, Eckerle I. High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Tropical Med Int Health. 2015;20:807–812. doi: 10.1111/tmi.12482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gautret P, Benkouiten S, Al-Tawfiq JA, Memish ZA. The spectrum of respiratory pathogens among returning Hajj pilgrims: myths and reality. Int J Infect Dis. 2016;47:83–85. doi: 10.1016/j.ijid.2016.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Aberle JH, Popow-Kraupp T, Kreidl P, Laferl H, Heinz FX, Aberle SW. Influenza A and B viruses but Not MERS-CoV in Hajj Pilgrims, Austria, 2014. Emerg Infect Dis. 2015;21(4):726–727. doi: 10.3201/eid2104.141745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Lessler J, Rodriguez-Barraquer I, Cummings DA, Garske T, Van Kerkhove M, Mills H, et al. Estimating potential incidence of MERS-CoV associated with Hajj Pilgrims to Saudi Arabia, 2014. PLoS Curr. 2014;24:6. doi: 10.1371/currents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Zumla A, Mwaba P, Bates M, Al-Tawfiq JA, Maeurer M, Memish ZA. The Hajj pilgrimage and surveillance for Middle East respiratory syndrome coronavirus in pilgrims from African countries. Tropical Med Int Health. 2014;19(7):838–840. doi: 10.1111/tmi.12318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, Drali T, Salez N, Memish ZA, al Masri M, Lagier JC, Million M, Raoult D, Brouqui P, Parola P. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014;20(4):728–730. doi: 10.3201/eid2004.131708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Memish ZA, Assiri A, Almasri M, Alhakeem RF, Turkestani A, Al Rabeeah AA, et al. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis. 2014;210(7):1067–1072. doi: 10.1093/infdis/jiu150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Gautret P, Charrel R, Belhouchat K, Drali T, Benkouiten S, Nougairede A, Zandotti C, Memish ZA, al Masri M, Gaillard C, Brouqui P, Parola P. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect. 2013;19(7):315–317. doi: 10.1111/1469-0691.12174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Hashem AM, Azhar EI, Shalhoub S, Abujamel TS, Othman NA, Al Zahrani AB, et al. Genetic characterization and diversity of circulating influenza A/H1N1pdm09 viruses isolated in Jeddah, Saudi Arabia between 2014 and 2015. Arch Virol. 2018;163(5):1219–1230. doi: 10.1007/s00705-018-3732-y. [DOI] [PubMed] [Google Scholar]
  • 47.Zumla A, Saeed AB, Alotaibi B, Yezli S, Dar O, Bieh K, Bates M, Tayeb T, Mwaba P, Shafi S, McCloskey B, Petersen E, Azhar EI. Tuberculosis and mass gatherings-opportunities for defining burden, transmission risk, and the optimal surveillance, prevention, and control measures at the annual Hajj pilgrimage. Int J Infect Dis. 2016;47:86–91. doi: 10.1016/j.ijid.2016.02.003. [DOI] [PubMed] [Google Scholar]
  • 48.Yezli S, Zumla A, Yassin Y, Al-Shangiti AM, Mohamed G, Turkistani AM, et al. Undiagnosed active pulmonary tuberculosis among pilgrims during the 2015 Hajj mass gathering: a prospective cross-sectional study. Am J Trop Med Hyg. 2017;97(5):1304–1309. doi: 10.4269/ajtmh.17-0271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Gautret P, Benkouiten S, Sridhar S, Al-Tawfiq JA, Memish ZA. Diarrhea at the Hajj and Umrah. Travel Med Infect Dis. 2015;13(2):159–166. doi: 10.1016/j.tmaid.2015.02.005. [DOI] [PubMed] [Google Scholar]
  • 50.Emamian MH, Mohammad Mohammadi G. An outbreak of gastroenteritis among Iranian pilgrims of Hajj during 2011. Iran Red Crescent Med J. 2013;15(4):317–319. doi: 10.5812/ircmj.3681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Gautret P, Benkouiten S, Parola P, Brouqui P, Memish Z, Raoult D. Occurrence of Tropheryma whipplei during diarrhea in Hajj pilgrims: a PCR analysis of paired rectal swabs. Travel Med Infect Dis. 2014;12(5):481–484. doi: 10.1016/j.tmaid.2014.04.003. [DOI] [PubMed] [Google Scholar]
  • 52.Sow Doudou, Dogue Fabiola, Edouard Sophie, Drali Tassadit, Prades Ségolène, Battery Emilie, Yezli Saber, Alotaibi Badriah, Sokhna Cheikh, Raoult Didier, Parola Philippe, Gautret Philippe. Acquisition of enteric pathogens by pilgrims during the 2016 Hajj pilgrimage: A prospective cohort study. Travel Medicine and Infectious Disease. 2018;25:26–30. doi: 10.1016/j.tmaid.2018.05.017. [DOI] [PubMed] [Google Scholar]
  • 53.Abd El Ghany M, Alsomali M, Almasri M, Padron Regalado E, Naeem R, Tukestani A, et al. Enteric Infections Circulating during Hajj Seasons, 2011–2013. Emerg Infect Dis. 2017;23(10). 10.3201/eid2310.161642. [DOI] [PMC free article] [PubMed]
  • 54.Metanat M, Sharifi-Mood B, Sanei-Moghaddam S, Rad NS. Pharyngeal carriage rate of Neisseria meningitidis before and after the Hajj pilgrimage, in Zahedan (southeastern Iran), 2012. Turk J Med Sci. 2015;45(6):1317–1320. doi: 10.3906/sag-1405-7. [DOI] [PubMed] [Google Scholar]
  • 55.Leangapichart T, Tissot-Dupont H, Raoult D, Memish ZA, Rolain JM, Gautret P. Risk factors for acquisition of CTX-M genes in pilgrims during Hajj 2013 and 2014. J Antimicrob Chemother. 2017;72(9):2627–2635. doi: 10.1093/jac/dkx155. [DOI] [PubMed] [Google Scholar]
  • 56.Bawazir SA. Prescribing pattern at community pharmacies in Saudi Arabia. Int Pharm J. 1992;6(5):222–224. [Google Scholar]
  • 57.Azeem M, Tashani M, Barasheed O. Knowledge, attitude and practice (KAP) survey concerning antimicrobial use among Australian Hajj pilgrims. Infect Disord Drug Targets. 2014;14:125–132. doi: 10.2174/1871526514666140713161757. [DOI] [PubMed] [Google Scholar]
  • 58.Haseeb A, Faidah HS, Bakhsh AR, Malki WH, Elrggal ME, Saleem F, et al. Antimicrobial resistance among pilgrims: a retrospective study from two hospitals in Makkah, Saudi Arabia. Int J Infect Dis. 2016;47:92–94. doi: 10.1016/j.ijid.2016.06.006. [DOI] [PubMed] [Google Scholar]
  • 59.Alyamani EJ, Khiyami AM, Booq RY, Majrashi MA, Bahwerth FS, Rechkina E. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia. Ann Clin Microbiol Antimicrob. 2017;16:1. doi: 10.1186/s12941-016-0177-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Leangapichart T, Dia NM, Olaitan AO, Gautret P, Brouqui P, Rolain J-M. Acquisition of extended-spectrum b-lactamases by Escherichia coli and Klebsiella pneumoniae in gut microbiota of pilgrims during the hajj pilgrimage of 2013. Antimicrob Agents Chemother. 2016;60:3222–3226. doi: 10.1128/AAC.02396-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Leangapichart T, Gautret P, Griffiths K, Belhouchat K, Memish Z, Raoult D, Rolain JM. Acquisition of a high diversity of bacteria during the Hajj pilgrimage, including Acinetobacter baumannii with blaOXA-72 and Escherichia coli with blaNDM-5 carbapenemase genes. Antimicrob Agents Chemother. 2016;60:5942–5948. doi: 10.1128/AAC.00669-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Olaitan AO, Dia NM, Gautret P, Benkouiten S, Belhouchat K, Drali T, Parola P, Brouqui P, Memish Z, Raoult D, Rolain JM. Acquisition of extended-spectrum cephalosporin- and colistin-resistant Salmonella enterica subsp. enterica serotype Newport by pilgrims during Hajj. Int J Antimicrob Agents. 2015;45(6):600–604. doi: 10.1016/j.ijantimicag.2015.01.010. [DOI] [PubMed] [Google Scholar]
  • 63.Leangapichart T, Gautret P, Brouqui P, Memish ZA, Raoult D, Rolain J-M. Acquisition of mcr-1 plasmid-mediated colistin resistance in Escherichia coli and Klebsiella pneumoniae during Hajj 2013 and 2014. Antimicrob Agents Chemother. 2016;60(11):6998–6999. doi: 10.1128/AAC.01486-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Al-Tawfiq JA, Memish ZA. Potential risk for drug resistance globalization at the Hajj. Clin Microbiol Infect. 2015;21(2):109–114. doi: 10.1016/j.cmi.2014.11.013. [DOI] [PubMed] [Google Scholar]
  • 65.WHO. Health conditions for travelers to Saudi Arabia for the pilgrimage to Mecca (Hajj). 4 August 2017. Available at: http://www.who.int/ith/updates/20170408/en/.
  • 66.Yezli S, Wilder-Smith A, Bin Saeed AA. Carriage of Neisseria meningitidis in the Hajj and Umrah mass gatherings. Int J Infect Dis. 2016;47:65–70. doi: 10.1016/j.ijid.2015.11.014. [DOI] [PubMed] [Google Scholar]
  • 67.Memish ZA, Yezli S, Almasri M, Assiri A, Turkestani A, Findlow H, Bai X, Borrow R. Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims. Int J Infect Dis. 2014;28:171–175. doi: 10.1016/j.ijid.2014.09.005. [DOI] [PubMed] [Google Scholar]
  • 68.Ceyhan M., Celik M., Demir E. T., Gurbuz V., Aycan A. E., Unal S. Acquisition of Meningococcal Serogroup W-135 Carriage in Turkish Hajj Pilgrims Who Had Received the Quadrivalent Meningococcal Polysaccharide Vaccine. Clinical and Vaccine Immunology. 2012;20(1):66–68. doi: 10.1128/CVI.00314-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Memish ZA, Al-Tawfiq JA, Almasri M, Azhar EI, Yasir M, Al-Saeed MS, et al. Neisseria meningitidis nasopharyngeal carriage during the Hajj: a cohort study evaluating the need for ciprofloxacin prophylaxis. Vaccine. 2017;35(18):2473–2478. doi: 10.1016/j.vaccine.2017.03.027. [DOI] [PubMed] [Google Scholar]
  • 70.Sokhna C, Mboup BM, Sow PG, Camara G, Dieng M, Sylla M, et al. Communicable and non-communicable disease risks at the Grand Magal of Touba: The largest mass gathering in Senegal. Travel Med Infect Dis. 2017;19:56–60. doi: 10.1016/j.tmaid.2017.08.005. [DOI] [PubMed] [Google Scholar]
  • 71.Sridhar S, Gautret P, Brouqui P. A comprehensive review of the Kumbh Mela: identifying risks for spread of infectious diseases. Clin Microbiol Infect. 2015;21(2):128–133. doi: 10.1016/j.cmi.2014.11.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Cariappa MP, Singh BP, Mahen A, Bansal AS. Kumbh Mela 2013: Healthcare for the millions. Med J Armed Forces India. 2015;71(3):278–281. doi: 10.1016/j.mjafi.2014.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Al-Lami F, Al-Fatlawi A, Bloland P, Nawwar A, Jetheer A, Hantoosh H, et al. Pattern of morbidity and mortality in Karbala hospitals during Ashura mass gathering at Karbala, Iraq, 2010. East Mediterr Health J. 2013;19(Suppl 2):S13–S20. doi: 10.26719/2013.19.Supp2.S13. [DOI] [PubMed] [Google Scholar]
  • 74.Youbi M, Dghoughi N, Akrim M, Essolbi A, Barkia A, Azami AI, et al. Preparedness and health risks associated with Moulay Abdellah Amghar Moussem, Morocco, 2009–2010. East Mediterr Health J. 2013;19(Suppl 2):S19–S20. doi: 10.26719/2013.19.Supp2.S19. [DOI] [PubMed] [Google Scholar]
  • 75.Hassan S, Imtiaz R, Ikram N, Baig MA, Safdar R, Salman M, et al. Public health surveillance at a mass gathering: Urs of Baba Farid, Pakpattan district, Punjab, Pakistan, December 2010. East Mediterr Health J. 2013;19(Suppl 2):S24–S30. [PubMed] [Google Scholar]
  • 76.Abdullah S, Sharkas G, Sabri N, Iblan I, Abdallat M, Jriesat S, et al. Mass gathering in Aqaba, Jordan, during Eid Al Adha, 2010. East Mediterr Health J. 2013;19(Suppl 2):S29–S30. doi: 10.26719/2013.19.Supp2.S29. [DOI] [PubMed] [Google Scholar]
  • 77.Centers for Disease Control and Prevention (CDC) Outbreak of salmonellosis associated with consumption of pulled pork at a church festival-Hamilton County, Ohio, 2010. MMWR Morb Mortal Wkly Rep. 2014;62:1045–1047. [PMC free article] [PubMed] [Google Scholar]
  • 78.Botelho-Nevers E, Gautret P. Outbreaks associated to large open air festivals, including music festivals, 1980 to 2012. Euro Surveill. 2013;18:20426. doi: 10.2807/ese.18.11.20426-en. [DOI] [PubMed] [Google Scholar]
  • 79.Tabunga T, Utiera M, Tekoaua R, Tibwe T, Tira T, Toatu T, Duituturaga SE, Nilles E, Craig A. Response to a large rotavirus outbreak on South Tarawa, Kiribati, 2013. Western Pac Surveill Response J. 2014;5(2):9–14. doi: 10.5365/wpsar.2013.4.4.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Grgič-Vitek M, Frelih T, Ucakar V, Fafangel M, Jordan Markocic O, Prosenc K, Kraigher A. An outbreak of measles associated with an international dog show in Slovenia, November 2014. Eurosurveillance. 2015;20(3):21012. doi: 10.2807/1560-7917.ES2015.20.3.21012. [DOI] [PubMed] [Google Scholar]
  • 81.McCarthy M. Measles outbreak linked to Disney theme parks reaches five states and Mexico. BMJ. 2015;350:h436. doi: 10.1136/bmj.h436. [DOI] [PubMed] [Google Scholar]
  • 82.Kanai M, Kamiya H, Smith-Palmer A, Takahashi H, Hachisu Y, Fukusumi M, et al. Meningococcal disease outbreak related to the World Scout Jamboree in Japan, 2015. Western Pac Surveill Response J. 2017;8(2):25–30. doi: 10.5365/WPSAR.2016.7.3.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.le Polain de Waroux O, Saliba V, Cottrell S, Young N, Perry M, Bukasa A, et al. Summer music and arts festivals as hot spots for measles transmission: experience from England and Wales, June to October 2016. Euro Surveill. 2016;21(44). 10.2807/1560-7917.ES.2016.21.44.30390. [DOI] [PMC free article] [PubMed]
  • 84.Gautret P, Steffen R. Communicable diseases as health risks at mass gatherings other than Hajj: what is the evidence? Int J Infect Dis. 2016;47:46–52. doi: 10.1016/j.ijid.2016.03.007. [DOI] [PubMed] [Google Scholar]
  • 85.Gardy Jennifer L., Naus Monika, Amlani Ashraf, Chung Walter, Kim Hochan, Tan Malcolm, Severini Alberto, Krajden Mel, Puddicombe David, Sahni Vanita, Hayden Althea S., Gustafson Reka, Henry Bonnie, Tang Patrick. Whole-Genome Sequencing of Measles Virus Genotypes H1 and D8 During Outbreaks of Infection Following the 2010 Olympic Winter Games Reveals Viral Transmission Routes. Journal of Infectious Diseases. 2015;212(10):1574–1578. doi: 10.1093/infdis/jiv271. [DOI] [PubMed] [Google Scholar]
  • 86.Santibanez S, Prosenc K, Lohr D, Pfaff G, Jordan O, Mankertz A. Measles virus spread initiated at international mass gatherings in Europe, 2011. Eurosurveillance. 2014;19(35):20891. doi: 10.2807/1560-7917.ES2014.19.35.20891. [DOI] [PubMed] [Google Scholar]
  • 87.McCloskey B, Endericks T, Catchpole M, Zambon M, McLauchlin J, Shetty N, Manuel R, Turbitt D, Smith G, Crook P, Severi E, Jones J, Ibbotson S, Marshall R, Smallwood CAH, Isla N, Memish ZA, al-Rabeeah AA, Barbeschi M, Heymann DL, Zumla A. London 2012 Olympic and Paralympic Games: public health surveillance and epidemiology. Lancet. 2014;383(9934):2083–2089. doi: 10.1016/S0140-6736(13)62342-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Sile B, Mohammed H, Crook P, Hughes G, Mercer C, Cassel J, Coyne K, Hartley A, Hall V, Brook G. Epidemiology of sexually transmitted infections in visitors for the London 2012 Olympic games: a review of attendees at sexual health services. Sex Transm Dis. 2015;42(12):710–716. doi: 10.1097/OLQ.0000000000000370. [DOI] [PubMed] [Google Scholar]
  • 89.Smallwood CAH, Arbuthnott KG, Banczak-Mysiak B, Borodina M, Coutinho AP, Payne-Hallström L, Lipska E, Lyashko V, Miklasz M, Miskiewicz P, Nitzan D, Pokanevych I, Posobkiewicz M, Rockenschaub G, Sadkowska-Todys M, Sinelnik S, Smiley D, Tomialoic R, Yurchenko V, Memish ZA, Heymann D, Endericks T, McCloskey B, Zumla A, Barbeschi M. Euro 2012 European football championship finals: planning for a health legacy. Lancet. 2014;383(9934):2090–2097. doi: 10.1016/S0140-6736(13)62384-3. [DOI] [PubMed] [Google Scholar]
  • 90.van Beijsterveldt A M C, Thijs K M, Backx F J G, Steffen K, Brozičević V, Stubbe J H. Sports injuries and illnesses during the European Youth Olympic Festival 2013. British Journal of Sports Medicine. 2015;49(7):448–452. doi: 10.1136/bjsports-2014-094035. [DOI] [PubMed] [Google Scholar]
  • 91.Soligard T, Steffen K, Palmer-Green D, Aubry M, Grant ME, Meeuwisse W, Mountjoy M, Budgett R, Engebretsen L. Sports injuries and illnesses in the Sochi 2014 Olympic Winter Games. Br J Sports Med. 2015;49(7):441–447. doi: 10.1136/bjsports-2014-094538. [DOI] [PubMed] [Google Scholar]
  • 92.Aguiar M, Coelho GE, Rocha F, Mateus L, Pessanha JE, Stollenwerk N. Dengue transmission during the 2014 FIFA World Cup in Brazil. Lancet Infect Dis. 2015;15(7):765–766. doi: 10.1016/S1473-3099(15)00073-0. [DOI] [PubMed] [Google Scholar]
  • 93.Pesola A, Pärn T, Huusko S, Perevoščikovs J, Ollgren J, Salmenlinna S, Lienemann T, Gossner C, Danielsson N, Rimhanen-Finne R. Multinational outbreak of Salmonella Enteritidis infection during an international youth ice hockey competition in Riga, Latvia, preliminary report, March and April 2015. Eurosurveillance. 2015;20(20):21133. doi: 10.2807/1560-7917.ES2015.20.20.21133. [DOI] [PubMed] [Google Scholar]
  • 94.Soligard T, Steffen K, Palmer D, Alonso JM, Bahr R, Lopes AD, Dvorak J, Grant ME, Meeuwisse W, Mountjoy M, Pena Costa LO, Salmina N, Budgett R, Engebretsen L. Sports injury and illness incidence in the Rio de Janeiro 2016 Olympic Summer Games: a prospective study of 11274 athletes from 207 countries. Br J Sports Med. 2017;51(17):1265–1271. doi: 10.1136/bjsports-2017-097956. [DOI] [PubMed] [Google Scholar]
  • 95.Hamilton B, Exeter D, Beable S, Coleman L, Milne C. Zika virus and the Rio Olympic Games. Clin J Sport Med. 2017; 10.1097/JSM.0000000000000551. [DOI] [PubMed]
  • 96.Tavernise. No Zika cases reported during Rio Olympics, W.H.O. Says. New York Times; 2016. Available at: https://www.nytimes.com/2016/09/03/health/zika-rio-olympics.html. Accessed September 5, 2016.
  • 97.Sheridan. Multiple Outbreaks Threaten the 2018 Winter Olympics. The disease Daily 14 February 2018. Available at: http://www.healthmap.org/site/diseasedaily/article/multiple-outbreaks-threaten-2018-winter-olympics-21418
  • 98.Benkouiten S, Brouqui P, Gautret P. Non-pharmaceutical interventions for the prevention of RTIs during Hajj pilgrimage. Travel Med Infect Dis. 2014;12(5):429–442. doi: 10.1016/j.tmaid.2014.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Al-Tawfiq JA, Gautret P, Memish ZA. Expected immunizations and health protection for Hajj and Umrah 2018 -an overview. Travel Med Infect Dis. 2017;2017(19):2–7. doi: 10.1016/j.tmaid.2017.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Current Infectious Disease Reports are provided here courtesy of Nature Publishing Group

RESOURCES